CV:KHRN Khiron Life Sciences Corp

Khiron Life Sciences Corp. operates as an integrated cannabis company in Latin America. It operates through four business units: Pharma Medical, Khiron Clinics, Wellness, and Dixie JV. The company focuses on the cultivation, production, distribution, and export of THC (tetrahydrocannabinol) and CBD (cannabidiol) medical cannabis. It also develops CBD-based cosmeceutical products for women and men's categories; and operates the company owned medical clinics. In addition, the company develops cannabis products in the food and beverage, supplements, and pets categories. The company was founded in 2017 and is headquartered in Vancouver, Canada.

This company cross-lists their shares on a U.S. stock exchange. See the related U.S. symbol KHRNF.

This company has cross-listed shares that trade in the U.S. as the symbol KHRNF.

0.09 CAD
As of 11/28/2022


Security Information
Category1:  Global Equity
Category2:  Common stocks
Category3:  Developed markets ex-US
GICS sector:  Unknown
Industry:  Drug Manufacturers-Specialty &
Index country:  Canada
Country of incorporation:  Canada
IPO date:  05/24/2018
Stock exchange:    TSX Venture Exchange
Exchange country:   Canada
Market cap:   29,578,232 CAD
Current dividend yield:   0.00%
Sedol:      BDGH0L6

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy